Your browser doesn't support javascript.
loading
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.
Finci, Iris; Albertini, Audrey; Merker, Matthias; Andres, Sönke; Bablishvili, Nino; Barilar, Ivan; Cáceres, Tatiana; Crudu, Valeriu; Gotuzzo, Eduardo; Hapeela, Nchimunya; Hoffmann, Harald; Hoogland, Christine; Kohl, Thomas A; Kranzer, Katharina; Mantsoki, Anna; Maurer, Florian P; Nicol, Mark P; Noroc, Ecaterina; Plesnik, Sara; Rodwell, Timothy; Ruhwald, Morten; Savidge, Theresa; Salfinger, Max; Streicher, Elizabeth; Tukvadze, Nestani; Warren, Robin; Zemanay, Widaad; Zurek, Anna; Niemann, Stefan; Denkinger, Claudia M.
Afiliación
  • Finci I; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.
  • Albertini A; FIND, Geneva, Switzerland.
  • Merker M; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany; Evolution of the Resistome, Research Center Borstel, Borstel, Germany; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Hamburg-Borstel-Lübeck-Riems, German
  • Andres S; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany.
  • Bablishvili N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Barilar I; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Hamburg-Borstel-Lübeck-Riems, Germany.
  • Cáceres T; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
  • Crudu V; Phthisiopneumology Institute Chiril Draganiuc, Chisinau, Moldova.
  • Gotuzzo E; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
  • Hapeela N; Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Hoffmann H; SYNLAB Gauting, SYNLAB MVZ Dachau, Gauting, Germany; Institute of Microbiology and Laboratory Medicine (IML Red), WHO Supranational TB Reference Laboratory, Gauting, Germany.
  • Hoogland C; FIND, Geneva, Switzerland.
  • Kohl TA; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Hamburg-Borstel-Lübeck-Riems, Germany.
  • Kranzer K; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Biomedical Research and Training Institute, Harare, Zimbabwe.
  • Mantsoki A; FIND, Geneva, Switzerland.
  • Maurer FP; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Nicol MP; Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
  • Noroc E; Phthisiopneumology Institute Chiril Draganiuc, Chisinau, Moldova.
  • Plesnik S; Institute of Microbiology and Laboratory Medicine (IML Red), WHO Supranational TB Reference Laboratory, Gauting, Germany.
  • Rodwell T; FIND, Geneva, Switzerland; Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA, USA.
  • Ruhwald M; FIND, Geneva, Switzerland.
  • Savidge T; Advanced Diagnostic Laboratories, National Jewish Health, Denver, CO, USA; Alaska State Public Health Laboratories, Anchorage, AK, USA.
  • Salfinger M; College of Public Health, University of South Florida, Tampa, FL, USA; Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Streicher E; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Tukvadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Warren R; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Zemanay W; Division of Medical Microbiology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Zurek A; Advanced Diagnostic Laboratories, National Jewish Health, Denver, CO, USA.
  • Niemann S; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany; National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany; Hamburg-Borstel-Lübeck-Riems, Germany.
  • Denkinger CM; FIND, Geneva, Switzerland; German Center for Infection Research, Heidelberg, Germany; Division of Clinical Tropical Medicine and German Centre for Infection Research, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: claudia.denkinger@uni-heidelberg.de.
Lancet Microbe ; 3(9): e672-e682, 2022 09.
Article en En | MEDLINE | ID: mdl-35907429
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis / Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis / Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Lancet Microbe Año: 2022 Tipo del documento: Article País de afiliación: Alemania